TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway

Temozolomide (TMZ) resistance is a complication of treatment of glioma, and new strategies are urgently required to overcome chemoresistance in glioma cells. In the present study, it was demonstrated that tripartite motif-containing 31 (TRIM31) was abnormally upregulated in glioma tissues and cell l...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Ming-De, Zhao, Xue-Ying, Qi, Jian-Ni, Jiang, Yang, Liu, Bing-Yu, Dun, Zhi-Ping, Zhang, Rui, Wang, Cheng-Wei, Pang, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388422/
https://www.ncbi.nlm.nih.gov/pubmed/32765650
http://dx.doi.org/10.3892/etm.2020.8782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388422/
https://www.ncbi.nlm.nih.gov/pubmed/32765650
http://dx.doi.org/10.3892/etm.2020.8782

Ejemplares similares